Conference
Inotuzumab ozogamicin and DLI can induce molecular remission in acute lymphoblastic leukemia relapse after allogeneic HSCT
Authors
Steinmann J; Berg T; Jedlickova Z; Ajib S; Farshi P; Riemann J; Lang F; Serve H; Gokbuget N; Bug G
Volume
52, Suppl. (P107)
Publication Date
November 10, 2017
Conference proceedings
Bone Marrow Transplantation